Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 22, 2017 - Issue 2
Submit an article Journal homepage
561
Views
10
CrossRef citations to date
0
Altmetric
Review

Emerging cell cycle inhibitors for acute myeloid leukemia

Abdallah Abou ZahrDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
&
Gautam BorthakurDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
Pages 137-148 | Received 25 Dec 2016, Accepted 12 May 2017, Published online: 22 May 2017

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Can Meng, Li Huang, Xiangjun Fu, Bin Wu & Lie Lin. (2022) RAB27B inhibits proliferation and promotes apoptosis of leukemic cells via 3-Hydroxy butyrate dehydrogenase 2 (BDH2). Bioengineered 13:3, pages 5103-5112.
Read now

Articles from other publishers (9)

Lin Zou, Ye Fang & Wei He. (2023) TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis. Molecular and Cellular Probes 69, pages 101911.
Crossref
Eric D. Eisenmann, Jack C. Stromatt, Sydney Fobare, Kevin M. Huang, Daelynn R. Buelow, Shelley Orwick, Jae Yoon Jeon, Robert H. Weber, Bill Larsen, Alice S. Mims, Erin Hertlein, John C. Byrd & Sharyn D. Baker. (2022) TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15:1, pages 29.
Crossref
Lingling Shi, Rui Huang & Yongrong Lai. (2021) Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia. BMC Medical Genomics 14:1.
Crossref
Samar J. Almehmadi, Amani M.R. Alsaedi, Marwa F. Harras & Thoraya A. Farghaly. (2021) Synthesis of a new series of pyrazolo[1,5-a]pyrimidines as CDK2 inhibitors and anti-leukemia. Bioorganic Chemistry 117, pages 105431.
Crossref
Wang Long, Sha Liu, Xiao-Xuan Li, Xin Shen, Jing Zeng, Jie-Si Luo, Ke-Ru Li, An-Guo Wu, Lu Yu, Da-Lian Qin, Guang-Qiang Hu, Jing Yang & Jian-Ming Wu. (2021) Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells. Pharmacological Research 166, pages 105491.
Crossref
Julia Quarti, Daianne N. M. Torres, Erika Ferreira, Raphael S. Vidal, Fabiana Casanova, Luciana B. Chiarini, Eliane Fialho & Vivian M. Rumjanek. (2021) Selective Cytotoxicity of Piperine over Multidrug Resistance Leukemic Cells. Molecules 26:4, pages 934.
Crossref
Amir Samii & Farnaz Razmkhah. (2020) Transformation of Hematopoietic Stem and Progenitor Cells by Leukemia Extracellular Vesicles: A Step Toward Leukemogenesis. Stem Cell Reviews and Reports 16:6, pages 1081-1091.
Crossref
Xingkai Du, Jian Li, Xiaojiao Luo, Rong Li, Feng Li, Yiwen Zhang, Jianyou Shi & Jun He. (2020) Structure-activity relationships of Wee1 inhibitors: A review. European Journal of Medicinal Chemistry 203, pages 112524.
Crossref
Sandip B. Bharate, Vikas Kumar, Shreyans K. Jain, Mubashir J. Mintoo, Santosh K. Guru, Vijay K. Nuthakki, Mohit Sharma, Sonali S. Bharate, Sumit G. Gandhi, Dilip M. Mondhe, Shashi Bhushan & Ram A. Vishwakarma. (2018) Discovery and Preclinical Development of IIIM-290, an Orally Active Potent Cyclin-Dependent Kinase Inhibitor. Journal of Medicinal Chemistry 61:4, pages 1664-1687.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.